- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ScinoPharm Taiwan Ltd (1789)
ScinoPharm Taiwan Ltd stock price live, this page displays TW 1789 stock exchange data. View the 1789 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ScinoPharm Taiwan Ltd real time stock price chart below.
What Is the ScinoPharm Taiwan Ltd Stock Price Today?
The ScinoPharm Taiwan Ltd stock price today is 21.60.
What Is the Stock Symbol for ScinoPharm Taiwan Ltd?
The stock symbol for ScinoPharm Taiwan Ltd is "1789."
What Stock Exchange Does ScinoPharm Taiwan Ltd Trade On?
ScinoPharm Taiwan Ltd is listed and trades on the Taiwan stock exchange.
Is ScinoPharm Taiwan Ltd a Good Stock to Buy?
Determining whether ScinoPharm Taiwan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1789 quote. (ISIN: TW0001789006)
What Is the ScinoPharm Taiwan Ltd Stock Price Today?
The ScinoPharm Taiwan Ltd stock price today is 21.60.
What Is the Stock Symbol for ScinoPharm Taiwan Ltd?
The stock symbol for ScinoPharm Taiwan Ltd is "1789."
What Stock Exchange Does ScinoPharm Taiwan Ltd Trade On?
ScinoPharm Taiwan Ltd is listed and trades on the Taiwan stock exchange.
Is ScinoPharm Taiwan Ltd a Good Stock to Buy?
Determining whether ScinoPharm Taiwan Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 1789 quote. (ISIN: TW0001789006)
Taiwan
Currency in TWD
21.60
+0.40(+1.89%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.25
21.65
52 wk Range
16.25
29.10
1789 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.2521.65
52 wk Range
16.2529.10
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.67%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.67%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1789 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
18.00
Downside
-16.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
Compare 1789 to Peers and Sector
Metrics to compare | 1789 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1789PeersSector | |
|---|---|---|---|---|
P/E Ratio | 124.7x | 35.3x | −0.5x | |
PEG Ratio | −2.07 | 0.55 | 0.00 | |
Price/Book | 1.6x | 3.6x | 2.6x | |
Price / LTM Sales | 5.4x | 5.9x | 3.2x | |
Upside (Analyst Target) | −16.7% | 21.6% | 43.6% | |
Fair Value Upside | Unlock | 6.6% | 4.9% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 18.00
(-16.67% Downside)
Earnings
Latest Release
Mar 05, 2026
EPS / Forecast
0.05 / 0.13
Revenue / Forecast
1.01B / 900M
FAQ
What Is the SPT (1789) Stock Price Today?
The SPT stock price today is 21.60 TWD.
What Stock Exchange Does SPT Trade On?
SPT is listed and trades on the Taiwan Stock Exchange.
What Is the Stock Symbol for SPT?
The stock symbol for SPT is "1789."
Does SPT Pay Dividends? What’s The Current Dividend Yield?
The SPT dividend yield is 1.67%.
What Is the SPT Market Cap?
As of today, SPT market cap is 17.32B TWD.
What Is SPT's Earnings Per Share (TTM)?
The SPT EPS (TTM) is 0.17.
When Is the Next SPT Earnings Date?
SPT will release its next earnings report on May 13, 2026.
From a Technical Analysis Perspective, Is 1789 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has SPT Stock Split?
SPT has split 6 times.
How Many Employees Does SPT Have?
SPT has 540 employees.
What is the current trading status of SPT (1789)?
As of Apr 18, 2026, SPT (1789) is trading at a price of 21.60 TWD, with a previous close of 21.00 TWD. The stock has fluctuated within a day range of 21.25 TWD to 21.65 TWD, while its 52-week range spans from 16.25 TWD to 29.10 TWD.
What Is SPT (1789) Price Target According to Analysts?
The average 12-month price target for SPT is 18.00 TWD, with a high estimate of 18 TWD and a low estimate of 18 TWD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -16.67% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.